Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Ching Chan Lin"'
Publikováno v:
Journal of Cancer Research and Practice, Vol 11, Iss 3, Pp 100-106 (2024)
Background: To evaluate the prognostic significance of adverse pathologic characteristics including lymphovascular invasion, perineural permeation, and squamous/sarcomatoid transformation in patients with urothelial tumors, and to analyze their corre
Externí odkaz:
https://doaj.org/article/ce815c61c0c9466ca8006720b4c1d1fa
Autor:
Yi‐Cheng Pan, Pei‐Yi Chu, Ching‐Chan Lin, Ching‐Yun Hsieh, Wei‐Yu Hsu, Lie‐Fen Shyur, Juan‐Cheng Yang, Wei‐Chao Chang, Yang‐Chang Wu
Publikováno v:
Molecular Oncology, Vol 18, Iss 8, Pp 1866-1884 (2024)
Bladder cancer poses a significant challenge to chemotherapy due to its resistance to cisplatin, especially at advanced stages. Understanding the mechanisms behind cisplatin resistance is crucial for improving cancer therapy. The enzyme glutathione S
Externí odkaz:
https://doaj.org/article/2b592489dea7445fbc623aa501dcb1dd
Autor:
Fu-Ming Cheng, Shih-Chang Lo, Ching-Chan Lin, Wen-Jyi Lo, Shang-Yu Chien, Ting-Hsuan Sun, Kai-Cheng Hsu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract This study aimed to evaluate the sensitivity of AI in screening acute leukemia and its capability to classify either physiological or pathological cells. Utilizing an acute leukemia orientation tube (ALOT), one of the protocols of Euroflow,
Externí odkaz:
https://doaj.org/article/05be5a387ce74629b6c6c381ae27c684
Autor:
Sze‐Ching Wong, Chun‐Chieh Yeh, Xun‐Yu Zhang, Chih‐Ying Hsieh, Chia‐Chien Lo, Ting‐Ting Kuo, Ching‐Chan Lin, Chih‐Hua Chao, Jing‐Pei Liu, Ling‐Chu Chang, Lu‐Hai Wang, Yuh‐Pyng Sher
Publikováno v:
Molecular Oncology, Vol 17, Iss 8, Pp 1648-1665 (2023)
CUB domain‐containing protein 1 (CDCP1) contributes to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) resistance by regulating EGFR signaling pathways and is a potential target in lung cancer treatment. This study aims to i
Externí odkaz:
https://doaj.org/article/353ae90eeedf4b26a5791f7b425b5f6c
Publikováno v:
Hematology Reports, Vol 15, Iss 1, Pp 50-56 (2023)
Myelodysplastic syndrome (MDS) immunity plays an important role in the proliferation and apoptosis of aberrant cells. Immune dysregulation has been studied in various prognostic subgroups. This study analyzed 60 patients with MDS via multidimensional
Externí odkaz:
https://doaj.org/article/edaa7536b5ba41e0b96999b9b8fbacf2
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 326-332 (2022)
Penile squamous cell carcinoma is a rare disease entity with poor overall survival in an advanced stage. Few studies have investigated the role of immunotherapy in advanced penile squamous cell carcinoma. Herein, we report a case of stage IV unresect
Externí odkaz:
https://doaj.org/article/9e8838d83b3c40ca8c669d0e9400d786
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 2887 (2023)
Taxanes, particularly docetaxel (DTX), has been widely used for combination therapy of head and neck squamous cell carcinoma (HNSCC). For locally advanced unresectable HNSCC, DTX combined with cisplatin and 5-fluorouracil as a revolutionary treatment
Externí odkaz:
https://doaj.org/article/24f8b41342b44363b670b9c6c087e2e9
Autor:
Ching-Yun Hsieh, Ming-Yu Lien, Chen-Yuan Lin, Wen-Jyi Lo, Chung-Hung Hua, Wei-Chao Chang, Chang-Fang Chiu, Ching-Chan Lin
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background The treatment of recurrent or metastatic head and neck squamous-cell carcinoma (R/M HNSCC) remains challenging. Preclinical studies revealed that B cell depletion could modulate the microenvironment and overcome chemoresistance. W
Externí odkaz:
https://doaj.org/article/b70aca47f87347549da07c0eb7c57ddf
Autor:
Ching-Yun Hsieh, Ching-Chan Lin, Yu-Wen Huang, Jong-Hang Chen, Yung-An Tsou, Ling-Chu Chang, Chi-Chen Fan, Chen-Yuan Lin, Wei-Chao Chang
Publikováno v:
JCI Insight, Vol 7, Iss 23 (2022)
Docetaxel (DTX) combined with cisplatin and 5-fluorouracil has been used as induction chemotherapy for head and neck squamous cell carcinoma (HNSCC). However, the development of acquired resistance remains a major obstacle to treatment response. Tumo
Externí odkaz:
https://doaj.org/article/de49d4ba9cf44e3eb6dce6025accedfc
Autor:
Sing-Ting Wang, Chia-Huei Chou, Tzu-Ting Chen, Ching-Chan Lin, Li-Yuan Bai, Shih-Peng Yeh, Mao-Wang Ho, Ming-Yu Lien
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
BackgroundAcute myeloid leukemia (AML) is a form of cancer that is characterized by infiltration of the bone marrow, blood, and other tissues by proliferative, clonal, abnormally differentiated, and occasionally poorly differentiated cells of the hem
Externí odkaz:
https://doaj.org/article/8b1639a197464420836028e01a382272